Chemist + Druggist is part of Pharma Intelligence UK Limited
This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
This copy is for your personal, non-commercial use. Please do not redistribute without permission.
Pharmacies in Wales will start offering “an extended range of services” from April next year, which will be backed by millions of pounds worth of funding, the Welsh government has announced.
The "substantial reforms" seen in the new three-year community pharmacy contract in Wales – negotiated by the government and Community Pharmacy Wales (CPW) – "represent the most fundamental change to the way pharmacies operate since the inception of the NHS more than 70 years ago", health minister Eluned Morgan said today (December 16).
Under the deal, funding for the new community pharmacy clinical service – which will see pharmacies offer services including treatment for “common minor ailments and some forms of emergency and regular contraception” – will increase from £11.4 million to £20m per year by 2024.
The government has also pledged to increase funding for independent prescribing services from £1.2m to £20.2m per year by 2024.
“Pharmacy funding [in Wales] next year will be £8.6m higher than it was three years ago,” Wales's chief pharmaceutical officer Andrew Evans told C+D yesterday (December 15), culminating in “a considerable investment in the sector overall”.
This will “ensure that pharmacies remain viable, remain sustainable”, and “have a solid platform from which to develop the clinical services we're talking about in our agreement”, he said.
Commenting on the agreement, CPW CEO Russell Goodway said: “This agreement bodes well for the community pharmacy network across Wales and will avoid the pitfalls facing colleagues in England, where funding for community pharmacies has been cut.”
The national clinical community pharmacy service is different from the NHS Pharmacy First service in Scotland, but has some similarities with it, Mr Evans told C+D.
It will “[bring] together some services that are already provided by pharmacies”, Mr Evans explained, such as a “national common ailments service, access to emergency contraception, emergency medicine supply, and also the seasonal influenza vaccination”.
While pharmacies can decide whether to offer the clinical services under the umbrella of the national clinical community pharmacy service, they will not be able to "opt into" any of the services offered in the package “without trying them all”, Mr Evans said.
This will create “a much more consistent universal offer for people who use pharmacies”, he added. Patients will “understand the sort of things they should expect whenever they visit a pharmacy”, which will limit them using “less appropriate parts of the NHS, like the GP or accident and emergency departments” for situations that do not warrant it.
Although other parts of the healthcare industry will be able to refer patients into pharmacies for these services, they “won't be conditional on referral”, Mr Evans added. Patients “will be able to walk in off the street without a referral from their GP”.
The agreement sets out a Wales-wide pharmacy prescribing service, enabling “appropriately trained pharmacists” to prescribe medicines for “acute illnesses like urinary tract and upper respiratory tract infections, and also prescribe routine contraception”, the Welsh government wrote in its statement.
“At this point in time, we've trained around 150 pharmacists as independent prescribers,” Mr Evans told C+D.
He added that the Welsh government will fund training for “at least 60 more every year” as part of its “commitment” to Health Education Improvement Wales.
Mr Evans is “really hopeful” that the deal will mean “pharmacists want to come and work in community pharmacies in Wales”.
“We want to make community pharmacy and Wales a really exciting place for pharmacists to come and work,” Mr Evans said.
The government’s investment in the sector will enable employers to "create packages and rewards for the pharmacists", he said, in turn drawing newly graduated pharmacists to work in Wales.
The government will also incentivise further use of pharmacy technicians by “offering training places on apprenticeship training for pharmacy technicians” and additional opportunities “to develop the skills of the wider pharmacy teams”.
In statements released this morning, the Company Chemists' Association (CCA) and the Royal Pharmaceutical Society (RPS) welcomed the new agreement between the Welsh government and CPW and the infusion of funding into Welsh community pharmacies.
The agreement places “a much greater focus on the provision of clinical services alongside the traditional role in supplying medicines”, the RPS said.
Meanwhile, CCA chief executive Malcolm Harrison argued that “contractors must now work together to maximise the delivery of clinical services within the sector”.
The nationally directed independent prescriber service in particular, he continued, “will play an important part in ensuring the retention of community pharmacists who have trained to become independent prescribers and incentivise them to continue their career in community pharmacy”.
Your account has not been activated. Please check and click the activation email, or click here to resend
Your account has not been activated. Please check and click the activation email, or click here to resend
Your login and/or password information does not match our records. Please try again.
Your login and/or password information does not match our records. Please try again.
Your username is marked inactive, please contact customer support.
Your username is marked blocked, please contact customer support.
Please check your email for an activation notice, and click the activation link.
Your account has not been activated. Please check and click the activation email, or click here to resend
Your account has not been activated. Please check and click the activation email, or click here to resend
Your login and/or password information does not match our records. Please try again.
Your login and/or password information does not match our records. Please try again.
Your username is marked inactive, please contact customer support.
Your username is marked blocked, please contact customer support.
Please check your email for an activation notice, and click the activation link.
Your username does not meet the requirements.
Sorry - this email domain is not allowed.
Sorry - public email accounts are not allowed. Please provide a work email address.
An account with that username already exists.
Unfortunately we've not been able to process your registration. Please contact support.
Please Note: You can also Click below Link for Ask the Analyst Ask The Analyst
Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.
Please make sure all fields are completed.
Please make sure you have filled out all fields
Please make sure you have filled out all fields
Please enter a valid e-mail address
Please enter a valid Phone Number
Ask your question to our analysts
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please make sure all fields are completed.
Please enter a valid e-mail address
Please make sure you have filled out all fields
Please make sure you have filled out all fields
Subject: Welsh government pumps cash into national pharmacy clinical service
Add a personalized message to your email
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.
Finish creating your saved search alert after you sign in
• C+D Daily • C+D CPD • C+D Review • C+D Careers • C+D Alerts • C+D Advertising
C+D has been informing, supporting and championing community pharmacy since 1859 and is proud to be at the forefront of providing the latest news to everyone working in the sector.
Copyright © 2022 Pharma Intelligence UK Limited Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London, SW1P 1WG. Pharma Intelligence UK Limited is part of the Pharma Intelligence Group.
This copy is for your personal, non-commercial use. Please do not redistribute without permission.